109622 ⎘
dsDNA viruses; Details; Adenoviridae; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Production of viral vectors
#302Method and compositions
#303E1-MINUS ADENOVIRUSES AND USE THEREOF
#304CD40 ligand fusion protein vaccine
#305Methods and compositions for suppressing virulence of methicillin resistant
#306Induced activation in dendritic cells
#307Adenoviral vectors comprising partial deletions of E3
#308Replication defective adenovirus vector in vaccination
#309AAV vectors with expanded packaging capacity
#310Splice variants of GDNF and uses thereof
#311Enhanced adoptive cell therapy
#312Engineered cells expressing multiple immunomodulators and uses thereof
#313VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER
#314GENETICALLY MODIFIED NON-HUMAN MAMMALS HAVING MODIFIED LIVER CELLS AND/OR TISSUE AND METHODS OF MAKING SAME
#315Modified Adenovirus Hexon Protein and Uses Thereof
#316Drug conjugates for delivering compounds to senescent cells
#317Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#318PPSA and Pspa polymer-virus complex and pharmaceutical compositions comprising the same
#319PHENOTYPIC REVERSION OF PANCREATIC CARCINOMA CELLS
#320Therapeutic HPV18 vaccines
#321Pharmaceutical composition comprising Nanog shRNA, and method of using Nanog shRNA to treat cancer
#322Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
#323Treatment using truncated Trk B and Trk C antagonists
#324Mucin antigen vaccine
#325PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof
#326FRAGILE HISTIDINE TRIAD (FHIT) COMPOSITIONS AND USES THEREOF
#327Capsid-mutated rAAV vectors and methods of use
#328Enhancing T cell activation using altered MHC-peptide ligands
#329Oncolytic adenoviruses for cancer treatment
#330Muscle-specific nucleic acid regulatory elements and methods and use thereof
#331MiRNA for treating diseases and conditions associated with neo-angiogenesis
#332Monoclonal antibody capable of binding integrin alpha 10 beta 1
#333Therapeutic miRNAs for treating heart and skeletal muscle diseases
#334System for electrically stimulating target neuronal cells of a living animal in vivo
#335OPTICAL TISSUE INTERFACE METHOD AND APPARATUS FOR STIMULATING CELLS
#336Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#337Penton-mutated, integrin-retargeted adenovirus vectors with reduced toxicity and their use
#338Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#339Pharmaceutical composition for preventing and treating cancer, containing CYB5R3 gene or protein as active ingredient
#340Method of making induced pluripotent stem cells
#341FMDV recombinant vaccines and uses thereof
#342SPARC (secreted protein, acidic and rich in cysteine), a new target for the treatment and prevention of acute liver failure
#343Adenovirus formulations
#344Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
#345Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#346Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
#347PREVENTION AND TREATMENT OF ATRIAL FIBRILLATION
#348-Prom mediated surface expression of avidin/streptavidin
#349Tripartite cancer theranostic nucleic acid constructs
#350Adenoviral vector encoding human atonal homolog-1 (HATH1)
#351Replication-competent adenoviral vectors
#352Methods and compositions for inducing protective immunity against human immunodeficiency virus infection
#353Isolated human cell with an inactivated glucocorticoid receptor gene
#354Replication defective adenovirus vector in vaccination
#355METHODS AND COMPOSITIONS FOR ATTENUATING GENE EDITING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES
#356METHODS AND COMPOSITIONS FOR ATTENUATING GENE THERAPY ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES
#357WNT MODULATORS FOR THE PROTECTION, MITIGATION AND TREATMENT OF RADIATION INJURY
#358Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
#359Methods and compositions for attenuating anti-viral transfer vector immune responses
#360Adenoviral assembly method
#361Pharmaceutical composition comprising Nanog shRNA, and method of using Nanog shRNA to treat cancer
#362Antiviral vaccines with improved cellular immunogenicity
#363Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#364MiR-204 and miR-211 and uses thereof
#365Rapid and prolonged immunologic-therapeutic
#366SAB as a Biomarker for Degenerative Diseases and Therapeutic Sensitivity in Cancers
#367Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin
#368VEGFR-3 ligand binding molecules and uses thereof
#369Oncolytic adenovirus compositions
#370NUCLEOTIDE VACCINE
#371Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analogues
#372A Helper-Dependent Adenoviral Gene Therapy Delivery and Expression System
#373METHOD AND COMPOSITION FOR TREATING SPASTICITY
#374PHENOTYPIC REVERSION OF PANCREATIC CARCINOMA CELLS
#375Oncolytic adenovirus armed with therapeutic genes
#376Induced activation in dendritic cells
#377Composition of viral vectors in lecithin liposomes, preparation method and treatment methods
#378ONCOLYTIC VIRUS ENCODING PD-1 BINDING AGENTS AND USES OF THE SAME
#379Constructs for enhancing immune responses
#380Enhanced adoptive cell therapy
#381Replication-competent adenoviral vectors
#382VECTORS FOR DELIVERY OF LIGHT SENSITIVE PROTEINS AND METHODS OF USE
#383Adenoviral vectors for transduction of vascular tissue
#384ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#385Nucleic acid complexes
#386SMOOTH MUSCLE SPECIFIC INHIBITION FOR ANTI-RESTENOTIC THERAPY
#387Modified serotype 28 adenoviral vectors
#388Methods for inducing migration by dendritic cells and an immune response
#389Matrix metalloproteinase cleavable protein polymers for cancer gene therapy
#390Herpes simplex virus vaccine
#391Adeno associated virus plasmids and vectors
#392Means and methods to increase adenovirus production
#393Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
#394Simian adenovirus 41 and uses thereof
#395Oncolytic Adenoviruses for Cancer Treatment
#396RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE
#397FAS-chimera adenovirus vector
#398Adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis
#399LPL variant therapeutics
#400Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#401Adenoviral vector-based malaria vaccines
#402Adenoviral vectors comprising partial deletions of E3
#403Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant
#404WDR13 as a novel biomarker useful for treating diabetes and cancer
#405Rapid and prolonged immunologic-therapeutic
#406Expression cassette for efficient surface display of antigenic proteins
#407Adenovirus serotype 26 and serotype 35 filovirus vaccines
#408Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL
#409Nucleic acid complexes
#410Compositions and methods for inducing migration by dendritic cells and an immune response
#411Induced activation in dendritic cells
#412Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#413VIRUS-MEDIATED DELIVERY OF BEVACIZUMAB FOR THERAPEUTIC APPLICATIONS
#414Phenotypic reversion of pancreatic carcinoma cells
#415Agent for use in the topical or local treatment of cervical dysplasias
#416Constructs for enhancing immune responses
#417Composition for treating HBV infection
#418Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#419Glucagon-like-peptide-2 (GLP-2) analogues
#420Rapid and prolonged immunologic-therapeutic
#421Adenovirus library and methods
#422IMMUNIZATION STRATEGY TO PREVENT H1N1 INFECTION
#423Simian adenovirus 41 and uses thereof
#424COMPOSITIONS AND METHODS FOR DETECTING OR ELIMINATING SENESCENT CELLS TO DIAGNOSE OR TREAT DISEASE
#425ENHANCING T CELL ACTIVATION USING ALTERED MHC-PEPTIDE LIGANDS
#426VECTORS FOR DELIVERY OF LIGHT SENSITIVE PROTEINS AND METHODS OF USE
#427Antiviral vaccines with improved cellular immunogenicity
#428E1-MINUS ADENOVIRUSES AND USE THEREOF
#429METHOD FOR OBTAINING A SINGULAR CELL MODEL CAPABLE OF REPRODUCING IN VITRO THE METABOLIC IDIOSYNCRASY OF HUMANS
#430Monoclonal antibody capable of binding integrin alpha 10 beta 1
#431Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof
#432RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE
#433Enhanced immune response against infections
#434Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancer
#435Engineered cells expressing multiple immunomodulators and uses thereof
#436METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE
#437Treatment of inflammatory bowel disease using glucagon-like-peptide-2 (GLP-2) analogues
#438LENTIVIRUS-BASED IMMUNOGENIC VECTORS
#439Glucagon-like-peptide-2 (GLP-2) analogues
#440Production of viral vectors
#441Increased T-cell tumor infiltration and eradication of metastases by mutant light
#442Splice variants of GDNF and uses thereof
#443NUCLEOTIDE VACCINE
#444Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin
#445Malaria antigen screening method
#446Compositions and Methods Related to Adenovirus Based Delivery of Antigens
#447Methods of Treating Various Cancers Using Melanoma Differentiating Associated Protein-7
#448Adenoviral vectors and methods and uses related thereto
#449Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
#450AUXILIARY REAGENT FOR GENE TRANSFER
#451Oncolytic Adenoviruses for Cancer Treatment
#452PHENOTYPIC REVERSION OF PANCREATIC CARCINOMA CELLS
#453CONSTRUCTS FOR ENHANCING IMMUNE RESPONSES
#454E1-MINUS ADENOVIRUSES AND USE THEREOF
#455VACCINE COMPOSITION
#456Monoclonal antibody capable of binding integrin alpha 10 beta 1
#457Oncolytic adenovirus armed with therapeutic genes
#458Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
#459Increased T-cell tumor infiltration and eradication of metastases by mutant light
#460Optical tissue interface method and apparatus for stimulating cells
#461Modified Adenovirus Hexon Protein and Uses Thereof
#462Compositions and Methods for Treatment of Vascular Grafts
#463Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#464Induced activation in dendritic cells
#465Method of inactivating a glucocorticoid receptor gene in an isolated cell
#466Phenotypic reversion of pancreatic carcinoma cells
#467Blockade of Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma by Insulin-Like Growth Factor Binding Protein-3 (Igfbp-3)
#468Methods of treating various cancers using melanoma differentiation associated protein-7
#469Method for Obtaining a Singular Cell Model Capable of Reproducing in Vitro the Metabolic Idiosyncrasy of Humans
#470Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#471Dendrite cells transduced with recombinant adenovirus AdVCEA which generate CEA-specific cytotoxic T lymphocytes, vaccine and pharmaceutical composition comprising the same
#472Glucagon-like-peptide-2 (GLP-2) analogues
#473Novel Sirna-Based Approach to Target the Hif-Alpha Factor for Gene Therapy
#474Gene Delivery System Containing Relaxin Gene And Pharmaceutical Composition Using Relaxin
#475Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein
#476Methods of treating chemotherapy-induced diarrhea/mucositis using glucagon-like-peptide-2(GLP-2)analogues
#477Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
#478Vaccines
#479Alkyl-glycoside enhanced vaccination
#480Gene therapeutics
#481Viral vectors and the use of the same for gene therapy
#482Oncolytic adenovirus armed with therapeutic genes
#483Monoclonal antibody capable of binding integrin alpha 10 beta 1
#484Use of negative regulatory elements for the neurospecific expression of transgenes
#485Replication-competent adenoviral vectors
#486Phenotypic reversion of pancreatic carcinoma cells
#487Akt and regulation of RA synovial fibroblast apoptosis
#488Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#489Cell specific gene silencing using cell-specific promoters in vitro and in vivo
#490Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus
#491Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
#492Mucin antigen vaccine
#493Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#494Combination therapies with L-FMAU for the treatment of hepatitis B virus infection
#495Methods of treating various cancers using melanoma differentiation associated protein-7
#496Method for obtaining a cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans
#497Modulation of gastrointestinal epithelium proliferation through the Wnt signaling pathway
#498Animal model for HCV infection
#499Lactate dehydrogenase as a novel target and reagent for diabetes therapy
#500Ebola virus composition/vaccine
#501PTP4A1 as a therapeutic target for fibrotic diseases and disorders including systemic sclerosis